SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-267186
Filing Date
2022-10-24
Accepted
2022-10-24 08:30:55
Documents
14
Period of Report
2022-10-24
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d308091d8k.htm   iXBRL 8-K 25136
2 EX-99.1 d308091dex991.htm EX-99.1 22185
6 GRAPHIC g308091g1022085312803.jpg GRAPHIC 5464
  Complete submission text file 0001193125-22-267186.txt   182626

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA rani-20221024.xsd EX-101.SCH 2885
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE rani-20221024_lab.xml EX-101.LAB 17980
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rani-20221024_pre.xml EX-101.PRE 11278
8 EXTRACTED XBRL INSTANCE DOCUMENT d308091d8k_htm.xml XML 3369
Mailing Address 2051 RINGWOOD AVENUE SAN JOSE CA 95131
Business Address 2051 RINGWOOD AVENUE SAN JOSE CA 95131 (408) 457-3700
Rani Therapeutics Holdings, Inc. (Filer) CIK: 0001856725 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40672 | Film No.: 221324879
SIC: 2834 Pharmaceutical Preparations